{
    "nctId": "NCT00757302",
    "briefTitle": "Intraoperative Gamma Camera for Breast Cancer Surgery",
    "officialTitle": "Evaluation of a New Intraoperative Gamma Camera for the Sentinel Lymph Node Procedure in Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Ductal Carcinoma in Situ",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 110,
    "primaryOutcomeMeasure": "Proportion of subjects for which the gamma camera can detect sentinel lymph nodes (SLN) not identified by other technic.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patient major at the time of breast surgery.\n* Patient affiliated with a social security.\n* Consent dated and signed by the investigator and the subject.\n* Subject having been informed of the sentinel lymph node procedure during the visit prior to breast surgery.\n* Patient having a unifocal infiltrative breast cancer (less than 2 cm) diagnosed preoperatively by core biopsy or cytology.\n* Patient having a ductal carcinoma in situ (DCIS), diagnosed preoperatively by core biopsy or cytology.\n\nExclusion Criteria:\n\n* Refusal of the patient to be included in the study.\n* Pregnant patient or during breastfeeding.\n* None of the patients will have undergone chemotherapy, locoregional radiotherapy or prevalent axillary lymph node.\n* Diagnosed safeguarding justice and trust.\n* Patient with a psychiatric disorder makes it impossible for the collection of informed consent-patient with tumors greater than 2 cm or multifocal.\n* Prevalent axillary lymph node.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}